Firm plans to supply amorphous selenium detectors to OEMsMedical imaging OEM supplier Analogic has taken a first step towards entering the digital x-ray market. The firm last week acquired the medical detector and pure metals assets of Noranda
Firm plans to supply amorphous selenium detectors to OEMs
Medical imaging OEM supplier Analogic has taken a first step towards entering the digital x-ray market. The firm last week acquired the medical detector and pure metals assets of Noranda Advanced Materials, a Canadian firm that has been developing an amorphous selenium-based digital detector product for the last three years.
Noranda has developed prototype detectors employing amorphous selenium, and expects to have models available for general radiographic and mammography applications in the spring of 2000. The Saint Laurent, Quebec-based firm had discussed progress with a detector targeted for mammography at the Society of Breast Imaging meeting in February.
Detectors suitable for angiography applications are also expected to be available in 2000, according to Bernard Gordon, Analogic chairman and CEO. Peabody, MA-based Analogic plans to bring a range of digital detector products to medical imaging OEMs through Anrad, a wholly owned subsidiary the company has formed to handle its digital detector business. Anrad will be based in a 35,000-square-foot facility previously occupied by Noranda in St. Laurent.
Noranda is currently providing amorphous selenium coating services for thin-film transistor arrays used in the DirectRay technology developed by Hologics Direct Radiography Corp. Anrad will continue to offer that kind of service, Gordon said.
In addition, Anrad could provide a detector plate, including readout and scanning electronics. Image filtering and correction interfacing necessary to hook the detector into an existing x-ray system could also be added, he said.
The company declined to comment on whether any firms have signed on to use Anrad technology. Anrad will be headed by president and chief technology officer Henri Rougeot, who continues on from Noranda. Noranda elected to sell its detector and pure metals assets to focus on its core electronic and zinc battery powder production businesses, Gordon said.
While nearly all flat-panel digital radiography systems employ amorphous silicon-based detectors, Analogic believes amorphous selenium will be competitive with that approach, offering price and resolution improvements, Gordon said. Furthermore, while some market watchers believe that amorphous selenium cant accommodate dynamic imaging, Analogic believes that technology developed at Noranda shows much potential in this realm.
With the acquisition, Analogic will enter a flat-panel digital x-ray market that has not lived up to expectations so far, hampered by a number of factors, including the high cost of these systems. The x-ray market is beginning to favor digital systems, but this trend is still in its infancy, Gordon said.
Were not going to see the same development that occurred when CT was first introduced, and suddenly everybody wanted to have one, he said. (Adoption of digital x-ray) is going to happen over a period of years.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.